Developing specialized antibodies for studying diseases in nonhuman primates

Magnani_P40_Resource Core

NIH-funded research Univ of Massachusetts Med Sch Worcester · NIH-10935285

This study is working on making special antibodies that can help scientists better understand diseases and treatments in nonhuman primates, which could eventually lead to better care for patients like you.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester NIH-funded
Lab location1 site (Worcester, United States)
Project IDNIH-10935285 on NIH RePORTER

What this research studies

This research focuses on creating tailored antibody reagents that can deplete specific lymphocyte subpopulations in nonhuman primates (NHPs). By enhancing the ability to study disease processes and treatment strategies, this project aims to improve our understanding of various health conditions. The methodology involves rigorous quality control and the production of high-quality monoclonal antibodies, which are essential for advancing NHP research in infectious diseases and transplantation. Patients may benefit indirectly through improved treatments developed from this research.

Who could benefit from this research

Good fit: Ideal candidates for benefiting from this research include individuals affected by infectious diseases or conditions requiring transplantation.

Not a fit: Patients with conditions that do not involve immune response or require NHP models may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and treatment options for diseases affecting humans.

How similar studies have performed: Previous research has shown success in using similar antibody development approaches to enhance understanding of disease mechanisms.

Where this research is happening

Worcester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.